MATSUI CONNIE

Insider Buys Quantity –
1
2021-11-05SaleHalozyme Therapeutics, Inc.
HALO
director
32,000
0.0226%
$40.38$1.29M+0.05%
2020-09-11SaleHalozyme Therapeutics, Inc.
HALO
director
32,000
0.0234%
$27.06$865,792+55.6%
2020-05-04PurchaseArtelo Biosciences, Inc.
ARTL
director
41,667
1.1357%
$1.20$50,000-9.45%
2007-01-16SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
24,823
0.0072%
$50.83$1.26M+6.53%
2006-10-16SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
40,000
0.0118%
$45.53$1.82M+10.14%
2006-07-17SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
40,000
0.012%
$42.73$1.71M+12.39%
2006-04-28SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
40,000
0.0118%
$45.28$1.81M+1.98%
2005-10-12SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
75,000
0.0227%
$36.49$2.74M+24.87%
2005-07-12SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
80,000
0.0237%
$36.23$2.9M+23.17%
2004-08-20SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
80,000
0.0236%
$59.02$4.72M-4.92%
2004-05-18SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
60,000
0.0178%
$59.06$3.54M+0.76%
2003-11-19SaleBiogen Inc.
BIIB
EVP, Corp. Strategy and Comm.
17,426
0.0005%
$3.50$60,991+64.18%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us